RecruitingPHASE2, PHASE3NCT06011889
Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome
Studying SAPHO syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland
- Principal Investigator
- Jakub Wroński, PhD, MDNational Institute of Geriatrics, Rheumatology and Rehabilitation
- Intervention
- Etanercept(drug)
- Enrollment
- 60 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2028
Study locations (1)
- Centrum Wsparcia Badań Klinicznych, Warsaw, Masovian Voivodeship, Poland
Collaborators
Medical Research Agency, Poland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06011889 on ClinicalTrials.govOther trials for SAPHO syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07081880Study of the Pathophysiological Mechanisms Involved in the SAPHO Syndrome: Genetic Component and Immune ResponseFondation Hôpital Saint-Joseph
- RECRUITINGNCT07086599Typological Study of Sleep Pathologies During Psoriatic Rheumatism and SAPHO Syndrome: Prospective Study Within the Paris Saint-Joseph Hospital Group"Fondation Hôpital Saint-Joseph